查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968570

兒童過敏診斷市場－全球產業規模、佔有率、趨勢、機會和預測：按過敏原、產品、檢測方法、地區和競爭對手分類，2021-2031年

Pediatric Allergy Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Allergen, By Product, By Test, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球兒童過敏診斷市場預計將從 2025 年的 25.3 億美元大幅成長至 2031 年的 47.3 億美元，複合年成長率為 10.99%。

此領域涵蓋多種專門用於檢測嬰幼兒和青少年過敏易感性的臨床檢測和程序，例如特異性IgE血液檢測、皮膚點刺試驗和口服食物激發試驗。推動該市場發展的主要因素是全球兒童過敏性疾病（尤其是氣喘和食物過敏）盛行率的不斷上升，使得早期準確檢測對於避免嚴重的健康後果至關重要。此外，飲食習慣的改變和日益嚴重的環境污染也加劇了特異性疾病的發生率，進一步增加了對有效診斷方法的需求。根據食物過敏研究與教育基金會2024年的患者登記數據，46%的食物過敏患者曾發生過敏性休克，凸顯了開發可靠診斷工具以應對日益成長的臨床負擔的緊迫性。

市場概覽
預測期 2027-2031
市場規模：2025年 25.3億美元
市場規模：2031年 47.3億美元
複合年成長率：2026-2031年 10.99%
成長最快的細分市場 食物
最大的市場 北美洲

儘管市場呈現成長態勢，但先進診斷設備的高成本仍是市場擴張的主要障礙，限制了資源匱乏地區獲得這些服務的機會。專業檢測平台所需的大量資金，加上開發中國家訓練有素的兒童過敏專家短缺，阻礙了這些關鍵醫療解決方案的廣泛應用。這些因素限制了經濟條件較差地區獲得必要的過敏診斷服務，對全球市場的滲透構成了明顯的障礙。

市場促進因素

全球兒童過敏性疾病發生率的激增是兒童過敏診斷市場的主要驅動力。為了應對日益增多的臨床病例，需要強大的檢測能力。這種成長在呼吸系統疾病和食物過敏領域尤其顯著，早期發現對於預防慢性健康問題和危及生命的過敏性休克至關重要。隨著盛行率的上升，醫療保健系統正致力於開發精準的篩檢工具，以區分真正的過敏和超敏反應。根據氣喘與過敏基金會於2025年4月發布的最新版《過敏狀況與統計》報告，美國約有400萬名兒童（佔兒童人口的5.8%）被診斷為食物過敏。這一人口趨勢正在推動診斷能力的市場擴張，以確保對弱勢兒童群體進行快速且準確的干涉。

同時，自動化檢測解決方案和先進的成分分解診斷 (CRD) 技術的整合正在改變市場。這些技術比傳統的全過敏原萃取物具有更高的準確性，使臨床醫生能夠精確識別特定的過敏原蛋白成分。這最大限度地減少了假陽性結果，並有助於實施標靶免疫療法。例如，Leviti 在 2025 年 5 月的新聞稿中宣布推出其全自動 IDS i20 平台，該平台能夠處理涵蓋過敏等多個診斷領域的 20 個分析參數，從而最佳化檢查室工作流程。這項技術進步得到了業界的大力投資支持。賽默飛世爾科技 (Thermo Fisher Scientific) 在 2025 年 10 月發布的 2025 年第三季財報中報告稱，其收入成長了 5%，達到 111.2 億美元，這凸顯了持續的經濟成長勢頭，推動了這些診斷設備的廣泛應用。

市場挑戰

先進診斷設備的高昂成本是全球兒童過敏診斷市場成長的主要障礙。這項經濟負擔嚴重限制了開發中國家和醫療預算有限的資源匱乏地區採用必要的檢測平台。因此，這些地區的醫療機構往往無法負擔精準口服食物激發試驗和特異性IgE血液檢測所需的專業設備。這種准入障礙阻礙了市場向易患特應性疾病的高危險群滲透，抑制了潛在的收入來源，並減緩了全球擴張。

人力和財力方面的限制導致缺乏可及的高品質診斷方法，從而嚴重影響了市場效率和患者照護。當先進的診斷工具無法獲得或價格過高時，醫療服務提供者被迫依賴準確性較低的方法，導致臨床療效欠佳，並進一步減少了對該領域的投資。據歐洲過敏與臨床免疫學會稱，到2024年，歐盟約有45%的過敏患者可能被誤診，這凸顯了這些持續存在的准入障礙導致現有市場基礎設施​​在有效評估和接觸患者方面存在重大缺陷。

市場趨勢

人工智慧 (AI) 與精準診斷的融合正在迅速重塑全球兒童過敏診斷市場，簡化工作流程並規範臨床評估結果的解釋。與容易出現觀察者間差異的傳統人工皮膚點刺試驗判讀相比，新興的 AI 驅動演算法能夠對風團反應進行客觀、自動化的分析，從而提高兒童人群診斷的一致性。這項技術透過簡化評估流程直接解決了臨床瓶頸問題，使醫療服務提供者能夠更有效地處理更多患者。根據發表於 2024 年 10 月《歐洲公共衛生雜誌》的論文《AI 增強型過敏診斷》，一項涉及約 300 名患者的臨床試驗表明，AI 輔助診斷使過敏科醫生平均每位患者的診療時間減少了 40 分鐘，顯著減輕了過敏治療中的人力負擔。

同時，市場正經歷一場技術變革，體外診斷方法正逐漸取代高風險的體內檢測，例如口服食物激發試驗。目前正在開發新的功能性檢測方法，這些方法能夠在受控的實驗室環境中模擬過敏反應，為診斷兒童和嬰兒的複雜食物過敏提供了一種安全有效的選擇，避免了過敏性休克的風險。這些先進的體外診斷技術透過測量細胞對特定過敏原的實際反應，提高了診斷準確性，優於標準的IgE檢測。例如，伯恩大學在2024年10月的新聞稿中宣布，研究人員開發了一種新的體外診斷方法—“Hoxb8肥大細胞活化檢測”，在兒童花生過敏病例中實現了95%的診斷準確率。這項結果超越了傳統血液檢測和皮膚試驗的可靠性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球兒童過敏診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依過敏原分類（食物、吸入性過敏原、其他過敏原）
    • 依產品（設備、服務）分類
    • 依測試類型（體外測試、體外測試）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美兒童過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲兒童過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區兒童過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲兒童過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲兒童過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球兒童過敏診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • bioMerieux SA
  • Thermo Fisher Scientific, Inc
  • Stallergenes Greer
  • Minaris Medical America Inc.
  • Siemens Healthineers AG
  • Cambridge Nutritional Sciences Plc（Omega Diagnostics Ltd）
  • R-Biopharm AESKU.GROUP GmbH & Co. KG
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25354

The Global Pediatric Allergy Diagnostics Market is projected to expand significantly, rising from a valuation of USD 2.53 billion in 2025 to USD 4.73 billion by 2031, reflecting a compound annual growth rate of 10.99%. This sector encompasses various clinical assays and procedures, including specific IgE blood analysis, skin prick testing, and oral food challenges, which are specifically tailored to detect allergic sensitivities in infants and adolescents. The primary force driving this market is the escalating global prevalence of pediatric allergic conditions, particularly asthma and food allergies, creating a critical need for early and precise detection to avert severe health consequences. Furthermore, shifting dietary habits and increasing environmental pollution are contributing to a higher incidence of atopic diseases, thereby intensifying the demand for effective diagnostic mechanisms. Data from the Food Allergy Research & Education patient registry in 2024 revealed that 46% of individuals with food allergies suffered from anaphylaxis, highlighting the urgent necessity for reliable diagnostic tools to address this mounting clinical burden.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.53 Billion
Market Size 2031USD 4.73 Billion
CAGR 2026-203110.99%
Fastest Growing SegmentFood
Largest MarketNorth America

Despite this growth trajectory, market expansion faces a substantial obstacle due to the high costs linked to advanced diagnostic instrumentation, which curtails accessibility in regions with limited resources. The significant financial outlay required for specialized testing platforms, combined with a scarcity of trained pediatric allergists in developing economies, impedes the widespread adoption of these vital healthcare solutions. These factors create a distinct barrier to global market penetration, restricting the availability of essential allergy diagnostics in areas where economic constraints prevail.

Market Driver

The surging global incidence of pediatric allergic conditions acts as the main engine for the pediatric allergy diagnostics market, requiring strong testing frameworks to handle growing clinical caseloads. This increase is especially notable in respiratory conditions and food allergies, where early detection is vital to prevent chronic health issues and life-threatening anaphylactic events. As prevalence rates rise, healthcare systems are focusing on accurate screening tools to distinguish between true allergies and sensitivities. According to the 'Allergy Facts and Figures' update released by the Asthma and Allergy Foundation of America in April 2025, approximately 4 million children in the United States, accounting for 5.8% of the pediatric population, have received a food allergy diagnosis. This demographic trend compels the market to broaden its diagnostic capabilities, ensuring timely and exact interventions for vulnerable pediatric groups.

Concurrently, the market is being transformed by the integration of automated laboratory solutions and advanced component-resolved diagnostic (CRD) technologies, which provide greater precision than traditional whole-allergen extracts. These innovations allow clinicians to pinpoint specific allergenic protein components, thereby minimizing false positives and facilitating targeted immunotherapy. For example, Revvity, Inc. announced in a May 2025 press release the launch of its IDS i20 platform, a fully automated system capable of processing 20 analytes across various diagnostic specialties, including allergy, to optimize laboratory workflows. This technological progression is bolstered by significant industry investment; Thermo Fisher Scientific reported in its 'Third Quarter 2025 Results' in October 2025 that revenue increased by 5% to $11.12 billion, underscoring the continued economic momentum that supports the broad deployment of these diagnostic instruments.

Market Challenge

The substantial expense linked to advanced diagnostic instrumentation serves as a formidable impediment to the growth of the global pediatric allergy diagnostics market. This financial load severely restricts the uptake of essential testing platforms in developing economies and resource-constrained regions where healthcare budgets are frequently limited. As a result, medical facilities in these locations often cannot afford the specialized equipment necessary for precise oral food challenges or specific IgE blood analysis. This lack of accessibility hinders the market from reaching extensive, high-population demographics that are increasingly prone to atopic diseases, thereby suppressing potential revenue streams and stalling global expansion.

The scarcity of accessible, high-quality diagnostics stemming from these workforce and financial limitations creates a significant deficit in market efficiency and patient care. When sophisticated tools are unavailable or unaffordable, healthcare providers are forced to depend on less accurate methods, resulting in suboptimal clinical outcomes that further discourage investment in the sector. According to the European Academy of Allergy and Clinical Immunology, approximately 45% of allergy patients within the European Union were likely misdiagnosed in 2024, emphasizing the critical failure of the existing market infrastructure to effectively evaluate and reach patients due to these persistent barriers to access.

Market Trends

The incorporation of artificial intelligence into precision diagnosis is swiftly reshaping the Global Pediatric Allergy Diagnostics Market by optimizing workflow efficiency and standardizing clinical assessment interpretations. In contrast to traditional manual readings of skin prick tests, which are prone to inter-observer variability, emerging AI-driven algorithms facilitate the objective, automated analysis of wheal reactions, thereby improving diagnostic consistency among pediatric populations. This technological adoption directly resolves clinical bottlenecks by streamlining evaluation processes, enabling healthcare providers to handle larger patient volumes more effectively. As reported in the 'AI-Enhanced Allergy Diagnostics' article by the European Journal of Public Health in October 2024, clinical trials with approximately 300 patients showed that AI-supported diagnostics cut the time needed for allergists by an average of 40 minutes per patient, significantly alleviating workforce pressures in allergy clinics.

Concurrently, the market is undergoing a major technological transition toward in vitro diagnostic modalities intended to supersede high-risk in vivo procedures such as oral food challenges. Novel functional assays are being developed to replicate allergic reactions within a controlled laboratory setting, providing a safer option for diagnosing complex food sensitivities in children and infants without the danger of triggering anaphylaxis. These advanced in vitro techniques offer enhanced diagnostic performance relative to standard IgE testing by gauging actual cellular responses to specific allergens. For instance, the University of Bern announced in an October 2024 press release regarding the 'Hoxb8 mast cell activation test' that researchers had created a new in vitro diagnostic method achieving 95% diagnostic accuracy in pediatric peanut allergy cases, exceeding the reliability of traditional blood and skin tests.

Key Market Players

  • bioMerieux SA
  • Thermo Fisher Scientific, Inc
  • Stallergenes Greer
  • Minaris Medical America Inc.
  • Siemens Healthineers AG
  • Cambridge Nutritional Sciences Plc(Omega Diagnostics Ltd)
  • R-Biopharm AESKU.GROUP GmbH & Co. KG
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.

Report Scope

In this report, the Global Pediatric Allergy Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Allergy Diagnostics Market, By Allergen

  • Food
  • Inhaled Drug
  • Other Allergens

Pediatric Allergy Diagnostics Market, By Product

  • Instruments
  • Services

Pediatric Allergy Diagnostics Market, By Test

  • In vivo Test
  • In vitro Test

Pediatric Allergy Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Allergy Diagnostics Market.

Available Customizations:

Global Pediatric Allergy Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pediatric Allergy Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Allergen (Food, Inhaled Drug, Other Allergens)
    • 5.2.2. By Product (Instruments, Services)
    • 5.2.3. By Test (In vivo Test, In vitro Test)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Pediatric Allergy Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Allergen
    • 6.2.2. By Product
    • 6.2.3. By Test
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pediatric Allergy Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Allergen
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Test
    • 6.3.2. Canada Pediatric Allergy Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Allergen
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Test
    • 6.3.3. Mexico Pediatric Allergy Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Allergen
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Test

7. Europe Pediatric Allergy Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Allergen
    • 7.2.2. By Product
    • 7.2.3. By Test
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pediatric Allergy Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Allergen
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Test
    • 7.3.2. France Pediatric Allergy Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Allergen
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Test
    • 7.3.3. United Kingdom Pediatric Allergy Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Allergen
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Test
    • 7.3.4. Italy Pediatric Allergy Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Allergen
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Test
    • 7.3.5. Spain Pediatric Allergy Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Allergen
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Test

8. Asia Pacific Pediatric Allergy Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Allergen
    • 8.2.2. By Product
    • 8.2.3. By Test
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pediatric Allergy Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Allergen
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Test
    • 8.3.2. India Pediatric Allergy Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Allergen
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Test
    • 8.3.3. Japan Pediatric Allergy Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Allergen
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Test
    • 8.3.4. South Korea Pediatric Allergy Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Allergen
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Test
    • 8.3.5. Australia Pediatric Allergy Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Allergen
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Test

9. Middle East & Africa Pediatric Allergy Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Allergen
    • 9.2.2. By Product
    • 9.2.3. By Test
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pediatric Allergy Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Allergen
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Test
    • 9.3.2. UAE Pediatric Allergy Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Allergen
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Test
    • 9.3.3. South Africa Pediatric Allergy Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Allergen
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Test

10. South America Pediatric Allergy Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Allergen
    • 10.2.2. By Product
    • 10.2.3. By Test
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pediatric Allergy Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Allergen
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Test
    • 10.3.2. Colombia Pediatric Allergy Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Allergen
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Test
    • 10.3.3. Argentina Pediatric Allergy Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Allergen
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Test

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pediatric Allergy Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. bioMerieux SA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc
  • 15.3. Stallergenes Greer
  • 15.4. Minaris Medical America Inc.
  • 15.5. Siemens Healthineers AG
  • 15.6. Cambridge Nutritional Sciences Plc(Omega Diagnostics Ltd)
  • 15.7. R-Biopharm AESKU.GROUP GmbH & Co. KG
  • 15.8. EUROIMMUN Medizinische Labordiagnostika AG
  • 15.9. HYCOR Biomedical
  • 15.10. Lincoln Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer